Your session is about to expire
← Back to Search
Omega-3 Fatty Acids for Diabetic Neuropathy (NMF Trial)
NMF Trial Summary
This trial is testing the hypothesis that fish oil-derived n-3 polyunsaturated fatty acids (n-3 PUFA) may improve sensorimotor and cardiovascular autonomic functions in people with impaired glucose tolerance.
NMF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNMF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NMF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are between 55 and 80 years old.You regularly take fish oil supplements or eat fatty fish more than twice a week.Your blood sugar levels are within a normal range after fasting and after having a sugary drink.Your blood sugar levels are within the normal range when tested after fasting or after drinking a sugary solution.You are being treated for type 2 diabetes, except with metformin.Your body mass index (BMI) is below 25 or above 39.9.You have serious problems with your brain, nerves, or other organs, or have trouble walking.Your blood sugar levels are higher than normal when you haven't eaten for a while, or after having a sugary drink.You must have a body mass index (BMI) between 25.0 and 39.9.Your body mass index (BMI) is between 25.0 and 39.9.You must be between 55 and 80 years old.You have a problem with alcohol, use illegal drugs, or smoke more than 20 cigarettes a week.The control group must have normal blood sugar levels, while the intervention groups can have higher-than-normal blood sugar levels.You exercise intensely for more than 150 minutes every week on a regular basis.You are younger than 55 or older than 80 years old.Your blood sugar levels are too high after not eating for a while or after drinking a sugary solution.
- Group 1: Intervention Group
- Group 2: Control group
- Group 3: Placebo Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the ultimate aim of this medical experiment?
"This clinical experiment, which will span 6 months in duration, seeks to evaluate Cardiovascular autonomic functioning. Additionally, Muscle strength, Oral insulin sensitivity index and Insulin secretion rate shall be observed as secondary outcomes."
Is the age limit for enrolment in this trial restricted to adults?
"This medical trial has outlined age restrictions as per their inclusion criteria. Prospective patients must be aged 55 or higher, but not over 80 years old."
Is it possible to participate in this clinical exploration?
"This research project is open to patients aged between 55 and 80 who suffer from diabetic neuralgia. 60 participants in total are required for the trial."
Is enrollment still open for this research initiative?
"According to clinicaltrials.gov, this research endeavour is still actively searching for participants since the initial posting on January 14th 2021 and last update on June 15th 2022."
What is the uppermost limit of participants in this trial?
"Affirmative, clinicaltrials.gov has the data to support that this medical trial is actively recruiting participants. This study was initially posted on January 14th 2021 and underwent its most recent update June 15th 2022. Two sites are required for 60 patients to qualify for inclusion in this experiment."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger